• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有二阶多项式治疗效果的临床试验的最优设计

Optimal designs for clinical trials with second-order polynomial treatment effects.

作者信息

Winkens Bjorn, Schouten Hubert J A, van Breukelen Gerard J P, Berger Martijn P F

机构信息

Department of Methodology and Statistics, University of Maastricht, Maastricht, The Netherlands.

出版信息

Stat Methods Med Res. 2007 Dec;16(6):523-37. doi: 10.1177/0962280206071847. Epub 2007 Aug 14.

DOI:10.1177/0962280206071847
PMID:17698939
Abstract

The effect of adding intermediate measures on the efficiency of treatment effect estimation is considered for a second-order polynomial treatment effect, equidistant time-points, different covariance structures and two optimality criteria, assuming either a fixed sample size or a fixed budget. The benefit of adding intermediate measures (at the expense of subjects) depends strongly on the assumed covariance structure and is hardly affected by the two used optimality criteria (Ds or c). For a fixed sample size, the increase in efficiency by adding intermediate measures is large for a compound symmetric structure and small for a first-order auto-regressive structure. For a first-order auto-regressive structure with measurement error, the results depend on the covariance parameter values. For a fixed budget and linear cost function, the design with only three measures per subject is often highly efficient. If the structure resembles compound symmetry and the cost per subject is eight or more times larger than the cost per repeated measure, however, more than three measures are required to obtain highly efficient treatment effect estimators. If the covariance structure is unknown, the optimal design based on a first-order auto-regressive structure with measurement error is preferable in terms of robustness against misspecification of the covariance structure. Given a design with three repeated measures and a second-order polynomial treatment effect, equidistant time-points are either optimal (Ds-) or highly efficient (c-optimality criterion). The results are illustrated by a practical example.

摘要

对于二阶多项式治疗效果、等距时间点、不同协方差结构以及两个最优性标准,在假设固定样本量或固定预算的情况下,考虑添加中间测量对治疗效果估计效率的影响。添加中间测量(以牺牲受试者数量为代价)的益处很大程度上取决于假设的协方差结构,并且几乎不受所使用的两个最优性标准(Ds 或 c)的影响。对于固定样本量,对于复合对称结构,添加中间测量带来的效率提升很大,而对于一阶自回归结构则很小。对于存在测量误差的一阶自回归结构,结果取决于协方差参数值。对于固定预算和线性成本函数,每个受试者仅进行三次测量的设计通常效率很高。然而,如果结构类似于复合对称,并且每个受试者的成本比每次重复测量的成本大八倍或更多倍,则需要进行三次以上的测量才能获得高效的治疗效果估计量。如果协方差结构未知,就协方差结构错误指定的稳健性而言,基于存在测量误差的一阶自回归结构的最优设计更可取。对于具有三次重复测量和二阶多项式治疗效果的设计,等距时间点要么是最优的(Ds -),要么是高效的(c - 最优性标准)。通过一个实际例子对结果进行了说明。

相似文献

1
Optimal designs for clinical trials with second-order polynomial treatment effects.具有二阶多项式治疗效果的临床试验的最优设计
Stat Methods Med Res. 2007 Dec;16(6):523-37. doi: 10.1177/0962280206071847. Epub 2007 Aug 14.
2
Optimal time-points in clinical trials with linearly divergent treatment effects.具有线性发散治疗效果的临床试验中的最佳时间点。
Stat Med. 2005 Dec 30;24(24):3743-56. doi: 10.1002/sim.2385.
3
Optimal number of repeated measures and group sizes in clinical trials with linearly divergent treatment effects.具有线性发散治疗效果的临床试验中重复测量的最佳次数和组大小
Contemp Clin Trials. 2006 Feb;27(1):57-69. doi: 10.1016/j.cct.2005.09.005. Epub 2005 Nov 2.
4
D-optimal cohort designs for linear mixed-effects models.线性混合效应模型的D-最优队列设计。
Stat Med. 2008 Jun 30;27(14):2586-600. doi: 10.1002/sim.3045.
5
Properties of internal pilots with the univariate approach to repeated measures.采用单变量方法进行重复测量时内部试验的特性。
Stat Med. 2003 Aug 15;22(15):2469-85. doi: 10.1002/sim.1466.
6
Optimal designs for empirical bayes estimators of individual linear and quadratic growth curves in linear mixed models.线性混合模型中个体线性和二次增长曲线的经验贝叶斯估计量的最优设计
Stat Methods Med Res. 2009 Aug;18(4):397-419. doi: 10.1177/0962280207088026. Epub 2008 Nov 26.
7
Randomized clinical trials with a pre- and a post-treatment measurement: repeated measures versus ANCOVA models.具有治疗前和治疗后测量的随机临床试验:重复测量与协方差分析模型。
Contemp Clin Trials. 2007 Nov;28(6):713-9. doi: 10.1016/j.cct.2007.04.002. Epub 2007 Apr 21.
8
Adaptive two-stage designs in phase II clinical trials.II期临床试验中的适应性两阶段设计。
Stat Med. 2006 Oct 15;25(19):3382-95. doi: 10.1002/sim.2501.
9
Robustness of optimal design of fMRI experiments with application of a genetic algorithm.基于遗传算法的 fMRI 实验优化设计的稳健性研究。
Neuroimage. 2010 Feb 1;49(3):2433-43. doi: 10.1016/j.neuroimage.2009.10.004. Epub 2009 Oct 13.
10
Optimal design of multi-subject blocked fMRI experiments.多受试者局部场磁共振成像实验的优化设计。
Neuroimage. 2011 Jun 1;56(3):1338-52. doi: 10.1016/j.neuroimage.2011.03.019. Epub 2011 Mar 23.

引用本文的文献

1
Optimal two-stage sampling for mean estimation in multilevel populations when cluster size is informative.多水平总体中当群大小为信息性时的均值估计的最优两阶段抽样。
Stat Methods Med Res. 2021 Feb;30(2):357-375. doi: 10.1177/0962280220952833. Epub 2020 Sep 17.
2
Optimal designs in three-level cluster randomized trials with a binary outcome.三水平整群随机临床试验中二分类结局的最优设计。
Stat Med. 2019 Sep 10;38(20):3733-3746. doi: 10.1002/sim.8153. Epub 2019 Jun 4.
3
Optimal design of longitudinal data analysis using generalized estimating equation models.
使用广义估计方程模型的纵向数据分析的优化设计。
Biom J. 2017 Mar;59(2):315-330. doi: 10.1002/bimj.201600107. Epub 2016 Nov 23.
4
Adding Subjects or Adding Measurements in Repeated Measurement Studies Under Financial Constraints.在资金受限的重复测量研究中增加研究对象或增加测量指标
Stat Biopharm Res. 2011 Feb 1;3(1):54-64. doi: 10.1198/sbr.2010.10022.